Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pavlakis, Nick"'
Autor:
Lemech C; Scientia Clinical Research Ltd, Sydney, New South Wales, Australia., Dredge K; Zucero Therapeutics Ltd, Brisbane, Queensland, Australia keith.dredge@zucero.com.au., Bampton D; Zucero Therapeutics Ltd, Brisbane, Queensland, Australia., Hammond E; Zucero Therapeutics Ltd, Brisbane, Queensland, Australia., Clouston A; Department of Pathology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Waterhouse NJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Stanley AC; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Leveque-El Mouttie L; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Chojnowski GM; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Haydon A; Medical Oncology, The Alfred Hospital, Melbourne, Victoria, Australia., Pavlakis N; Medical Oncology, Genesis Care, North Shore Health Hub, St Leonards, New South Wales, Australia.; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia., Burge M; Medical Oncology, The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Brown MP; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Goldstein D; Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1).
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.
Autor:
Smith S; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia., Brand M; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia., Harden S; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, Victoria, Australia.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Briggs L; Victorian Lung Cancer Registry, Monash University, Clayton, Victoria, Australia., Leigh L; Victorian Lung Cancer Registry, Monash University, Clayton, Victoria, Australia., Brims F; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia., Brooke M; Lung Foundation Australia, Milton, Queensland, Australia., Brunelli VN; Faculty of Health, School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia., Chia C; Department of Respiratory Medicine, Launceston General Hospital, Launceston, Tasmania, Australia., Dawkins P; Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand., Lawrenson R; Waikato Medical Research Centre, University of Waikato, Hamilton, Waikato, New Zealand.; Strategy and Funding, Waikato District Health Board, Hamilton, New Zealand., Duffy M; Lung Cancer Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Evans S; Victorian Cancer Registry, Cancer Council Victoria, Melbourne, Victoria, Australia., Leong T; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia., Marshall H; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia., Patel D; Department of Medical Oncology, Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia., Pavlakis N; Medical Oncology, Genesis Care and University of Sydney, Sydney, New South Wales, Australia., Philip J; Department of Medicine, Univ Melbourne, Fitzroy, Victoria, Australia., Rankin N; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Singhal N; Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia., Stone E; School of Clinical Medicine, University NSW, Sydney, Victoria, Australia., Tay R; Department of Medical Oncology, The Royal Hobart Hospital, Hobart, Tasmania, Australia., Vinod S; Cancer Therapy Centre, Liverpool Hospital, Liverpool, New South Wales, Australia., Windsor M; Department of Thoracic Surgery, Prince Charles and Royal Brisbane Hospital, Brisbane, Queensland, Australia., Wright GM; Department of Surgery, Cardiothoracic Surgery Unit, St Vincent, Victoria, Australia., Leong D; Department of Medical Oncology, John James Medical Centre Deakin, Canberra, Australian Capital Territory, Australia., Zalcberg J; Cancer Research Program, Monash University, Melbourne, Victoria, Australia., Stirling RG; Department of Medicine, Monash University, Clayton, Victoria, Australia r.stirling@alfred.org.au.; Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Publikováno v:
BMJ open [BMJ Open] 2022 Aug 29; Vol. 12 (8), pp. e060907. Date of Electronic Publication: 2022 Aug 29.
Autor:
Kok PS; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia peey-sei.kok@sydney.edu.au.; School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia., Forde PM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Hughes B; Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.; Medicine, The University of Queensland, Saint Lucia, Queensland, Australia., Sun Z; ECOG-ACRIN Biostatistics Center, Frontier Science Foundation, Boston, Massachusetts, USA., Brown C; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia., Ramalingam S; Winship Cancer Institute, Emory University, Atlanta, Georgia, USA., Cook A; National Centre for Asbestos Related Diseases (NCARD), Institute for Respiratory Health, Perth, Western Australia, Australia.; School of Biological Sciences, University of Western Australia, Perth, Western Australia, Australia., Lesterhuis WJ; Telethon Kids Institute, Nedlands, Western Australia, Australia., Yip S; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia., O'Byrne K; Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Queensland University of Technology, Brisbane, Queensland, Australia., Pavlakis N; Genesis Care, Sydney, New South Wales, Australia.; The University of Sydney, Sydney, New South Wales, Australia., Brahmer J; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Anagnostou V; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA., Ford K; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia., Fitzpatrick K; PrECOG, Philadelphia, Pennsylvania, USA., Bricker A; PrECOG, Philadelphia, Pennsylvania, USA., Cummins MM; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia., Stockler M; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia., Nowak AK; National Centre for Asbestos Related Diseases (NCARD), Institute for Respiratory Health, Perth, Western Australia, Australia.; Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Publikováno v:
BMJ open [BMJ Open] 2022 Jan 25; Vol. 12 (1), pp. e057663. Date of Electronic Publication: 2022 Jan 25.
Autor:
Ahern E; School of Clinical Sciences, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia elizabeth.ahern@monash.edu.; Medical Oncology, Monash Health, Clayton, Victoria, Australia.; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Solomon BJ; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hui R; Medical Oncology, Westmead Hospital, Westmead, New South Wales, Australia.; Faculty of Medicine, The University of Sydney, Sydney, New South Wales, Australia., Pavlakis N; Faculty of Medicine, The University of Sydney, Sydney, New South Wales, Australia.; Medical Oncology, Royal North Shore Hospital Northern Sydney Cancer Centre, St. Leonards, New South Wales, Australia., O'Byrne K; Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia., Hughes BGM; Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.; Medical Oncology, The Prince Charles Hospital, Chermside, Queensland, Australia.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).